US Stock MarketDetailed Quotes

PLRX Pliant Therapeutics

Watchlist
  • 14.030
  • +0.540+4.00%
Close Dec 26 16:00 ET
  • 14.030
  • 0.0000.00%
Post 16:37 ET
853.78MMarket Cap-4.19P/E (TTM)

Pliant Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-83.69%1.58M
0
0
-95.03%248K
6.65%1.33M
27.91%9.69M
-1.70%1.97M
Operating revenue
--0
--0
--0
-83.69%1.58M
--0
--0
-95.03%248K
6.65%1.33M
27.91%9.69M
-1.70%1.97M
Cost of revenue
Gross profit
Operating expense
30.05%62.01M
27.46%60.64M
20.64%52.39M
35.68%185.73M
19.49%47.04M
42.65%47.69M
37.38%47.58M
47.41%43.43M
30.23%136.89M
48.00%39.37M
Selling and administrative expenses
-7.08%14.26M
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
73.93%15.35M
75.68%14.57M
64.98%14.15M
44.96%39.95M
81.63%14.25M
-General and administrative expense
-7.08%14.26M
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
73.93%15.35M
75.68%14.57M
64.98%14.15M
44.96%39.95M
81.63%14.25M
Research and development costs
47.67%47.75M
38.22%45.62M
26.90%37.15M
31.84%127.8M
32.13%33.18M
31.43%32.34M
25.32%33M
40.19%29.27M
25.00%96.94M
33.93%25.11M
Operating profit
-30.05%-62.01M
-28.13%-60.64M
-24.46%-52.39M
-44.77%-184.15M
-25.77%-47.04M
-49.26%-47.69M
-59.67%-47.33M
-49.21%-42.1M
-30.41%-127.2M
-52.04%-37.4M
Net non-operating interest income expense
-31.41%4.25M
-22.02%4.79M
19.57%5.44M
488.01%22.81M
153.33%5.93M
365.32%6.2M
6,291.67%6.14M
3,996.40%4.55M
1,326.10%3.88M
3,341.18%2.34M
Non-operating interest income
-21.29%5.13M
-12.42%5.65M
21.08%5.88M
415.55%24.08M
135.19%6.25M
298.96%6.52M
2,299.63%6.46M
4,276.58%4.86M
1,616.91%4.67M
--2.66M
Non-operating interest expense
176.66%877K
172.10%868K
43.09%445K
60.18%1.27M
1.26%321K
5.32%317K
84.39%319K
--311K
--791K
--317K
Other net income (expense)
Income before tax
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
Income tax
Net income
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
Net income continuous Operations
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
Minority interest income
Net income attributable to the parent company
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-26.79%-123.32M
-42.92%-35.06M
Basic earnings per share
-35.71%-0.95
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
-7.69%-0.7
14.63%-0.7
14.10%-0.67
-8.49%-2.94
-5.88%-0.72
Diluted earnings per share
-35.71%-0.95
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
-7.69%-0.7
14.63%-0.7
14.10%-0.67
-8.49%-2.94
-5.88%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-83.69%1.58M00-95.03%248K6.65%1.33M27.91%9.69M-1.70%1.97M
Operating revenue --0--0--0-83.69%1.58M--0--0-95.03%248K6.65%1.33M27.91%9.69M-1.70%1.97M
Cost of revenue
Gross profit
Operating expense 30.05%62.01M27.46%60.64M20.64%52.39M35.68%185.73M19.49%47.04M42.65%47.69M37.38%47.58M47.41%43.43M30.23%136.89M48.00%39.37M
Selling and administrative expenses -7.08%14.26M3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M73.93%15.35M75.68%14.57M64.98%14.15M44.96%39.95M81.63%14.25M
-General and administrative expense -7.08%14.26M3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M73.93%15.35M75.68%14.57M64.98%14.15M44.96%39.95M81.63%14.25M
Research and development costs 47.67%47.75M38.22%45.62M26.90%37.15M31.84%127.8M32.13%33.18M31.43%32.34M25.32%33M40.19%29.27M25.00%96.94M33.93%25.11M
Operating profit -30.05%-62.01M-28.13%-60.64M-24.46%-52.39M-44.77%-184.15M-25.77%-47.04M-49.26%-47.69M-59.67%-47.33M-49.21%-42.1M-30.41%-127.2M-52.04%-37.4M
Net non-operating interest income expense -31.41%4.25M-22.02%4.79M19.57%5.44M488.01%22.81M153.33%5.93M365.32%6.2M6,291.67%6.14M3,996.40%4.55M1,326.10%3.88M3,341.18%2.34M
Non-operating interest income -21.29%5.13M-12.42%5.65M21.08%5.88M415.55%24.08M135.19%6.25M298.96%6.52M2,299.63%6.46M4,276.58%4.86M1,616.91%4.67M--2.66M
Non-operating interest expense 176.66%877K172.10%868K43.09%445K60.18%1.27M1.26%321K5.32%317K84.39%319K--311K--791K--317K
Other net income (expense)
Income before tax -39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M
Income tax
Net income -39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M
Net income continuous Operations -39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M
Minority interest income
Net income attributable to the parent company -39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M-26.79%-123.32M-42.92%-35.06M
Basic earnings per share -35.71%-0.95-31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69-7.69%-0.714.63%-0.714.10%-0.67-8.49%-2.94-5.88%-0.72
Diluted earnings per share -35.71%-0.95-31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69-7.69%-0.714.63%-0.714.10%-0.67-8.49%-2.94-5.88%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Adobe
ADBE
+0.50%
Lennar Corp
LEN
+0.46%
Petroleo Brasileiro SA Petrobras
PBR
+0.46%
Apple
AAPL
+0.32%
D.R. Horton
DHI
+0.30%

Unlock the Full List